PRDX1 and lip and oral cavity carcinoma: In oral cancer, PRDX1 is highly expressed and is significantly correlated with tumor staging, lymph node metastasis, and pathological grading, making it a promising biomarker for predicting lymph node metastasis and prognosis in oral cancer patients76.